News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,477 Results
Type
Article (40263)
Company Profile (271)
Press Release (661943)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205186)
Career Advice (2023)
Deals (35540)
Drug Delivery (97)
Drug Development (81267)
Employer Resources (172)
FDA (16236)
Job Trends (14924)
News (346624)
Policy (32663)
Tag
Academia (2575)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49816)
ALS (88)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (128)
Approvals (16240)
Artificial intelligence (256)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11667)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (279)
Cancer (2267)
Cardiovascular disease (175)
Career advice (1691)
Career pathing (30)
CAR-T (153)
Cell therapy (429)
Cervical cancer (19)
Clinical research (66133)
Collaboration (842)
Company closure (1)
Compensation (547)
Complete response letters (19)
COVID-19 (2605)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2212)
Decentralized trials (2)
Denatured (20)
Depression (44)
Diabetes (272)
Diagnostics (6397)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86795)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112988)
Executive appointments (729)
FDA (17505)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (755)
Gene editing (107)
Generative AI (19)
Gene therapy (303)
GLP-1 (713)
Government (4430)
Grass and pollen (4)
Guidances (67)
Healthcare (18849)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (120)
Indications (29)
Infectious disease (2748)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (96)
Interviews (312)
IPO (16544)
IRA (42)
Job creations (3666)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (475)
Leadership (17)
Legal (7946)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (306)
MASH (68)
Medical device (13413)
Medtech (13418)
Mergers & acquisitions (19541)
Metabolic disorders (689)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1923)
NextGen: Class of 2025 (6553)
Non-profit (4493)
Now hiring (39)
Obesity (364)
Opinion (209)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (85)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57653)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20631)
Phase II (29129)
Phase III (21683)
Pipeline (1207)
Policy (142)
Postmarket research (2564)
Preclinical (8774)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5955)
Recruiting (65)
Regulatory (22364)
Reports (46)
Research institute (2330)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (133)
Series B (85)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3631)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (30)
Vaccines (692)
Venture capitalists (43)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (34)
Last 7 days (859)
Last 30 days (2515)
Last 365 days (32765)
2025 (10816)
2024 (35343)
2023 (40196)
2022 (51308)
2021 (55860)
2020 (54178)
2019 (46667)
2018 (35161)
2017 (32250)
2016 (31662)
2015 (37738)
2014 (31490)
2013 (26547)
2012 (28827)
2011 (29476)
2010 (27562)
Location
Africa (722)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38092)
Australia (6248)
California (6167)
Canada (2020)
China (525)
Colorado (268)
Connecticut (274)
Delaware (148)
Europe (81901)
Florida (913)
Georgia (207)
Idaho (58)
Illinois (542)
India (26)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4591)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1729)
New Mexico (28)
New York (1750)
North Carolina (970)
North Dakota (8)
Northern California (2693)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1380)
Puerto Rico (12)
Rhode Island (34)
South America (1101)
South Carolina (23)
South Dakota (1)
Southern California (2319)
Tennessee (101)
Texas (914)
United States (23229)
Utah (181)
Virginia (147)
Washington D.C. (63)
Washington State (556)
West Virginia (3)
Wisconsin (54)
702,477 Results for "pulse biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
February 4, 2025
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
December 24, 2024
·
5 min read
Press Releases
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
January 10, 2025
·
4 min read
Press Releases
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting
May 1, 2025
·
4 min read
Press Releases
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting
April 23, 2025
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
December 19, 2024
·
1 min read
Press Releases
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025
April 25, 2025
·
1 min read
Press Releases
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 25, 2025
April 28, 2025
·
2 min read
Press Releases
Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
March 26, 2025
·
1 min read
Deals
Pulse Biosciences, Inc. Announces Commencement of Rights Offering - June 4, 2024
Pulse Biosciences, Inc. today announced that it has commenced its previously announced rights offering of up to $60,000,000 of units (the “Units,” and each, a “Unit”) at the Initial Price (as defined below).
June 4, 2024
·
7 min read
1 of 70,248
Next
